Review article · 2024 · Open access
Cutting-edge approaches to B-cell depletion in autoimmune diseases
Frontiers in Immunology, 15, 1454747 · Published 9 October 2024 · DOI 10.3389/fimmu.2024.1454747
In brief
“Cutting-edge approaches to B-cell depletion in autoimmune diseases” is a 2024 review article by William H. Robinson and 7 co-authors, published in Frontiers in Immunology. OpenAlex counts 53 citations as of 20 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.
- Citations
- 53
- Most cited in
- 2026 (32)
- Field-weighted impact
- 1.86
- References
- 58
- Authors
- 8
Abstract
B-cell depletion therapy (BCDT) has been employed to treat autoimmune disease for ~20 years. Immunoglobulin G1 (IgG1) monoclonal antibodies targeting CD20 and utilizing effector function (eg, antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis) to eliminate B cells have historically been the predominant therapeutic approaches. More recently, diverse BCDT approaches targeting a variety of B-cell surface antigens have been developed for use in hematologic malignancies, including effector-function-enhanced monoclonal antibodies, chimeric antigen receptor T-cell (CAR-T) treatment, and bispecific T-cell engagers (TCEs). The latter category of antibodies employs CD3 engagement to augment the killing of target cells. Given the improvement in B-cell depletion observed with CAR-T and TCEs compared with conventional monospecific antibodies for treatment of hematologic malignancies and the recent case reports demonstrating therapeutic benefit of CAR-T in autoimmune disease, there is potential for these mechanisms to be effective for B-cell-mediated autoimmune disease. In this review, we discuss the various BCDTs that are being developed in autoimmune diseases, describing the molecule designs, depletion mechanisms, and potential advantages and disadvantages of each approach as they pertain to safety, efficacy, and patient experience. Additionally, recent advances and strategies with TCEs are presented to help broaden understanding of the potential for bispecific antibodies to safely and effectively engage T cells for deep B-cell depletion in autoimmune diseases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Robinson, W. H., Fiorentino, D. F., Chung, L. S., Moreland, L. W., Deodhar, M., Harler, M., Saulsbery, C., & Kunder, R. S. (2024). Cutting-edge approaches to B-cell depletion in autoimmune diseases. Frontiers in Immunology, 15, 1454747. https://doi.org/10.3389/fimmu.2024.1454747
MLA 9
Robinson, William H., et al. “Cutting-edge approaches to B-cell depletion in autoimmune diseases.” Frontiers in Immunology, vol. 15, 2024, p. 1454747. https://doi.org/10.3389/fimmu.2024.1454747.
Chicago
Robinson, William H., David Franklin Fiorentino, Lorinda S Chung, Larry W. Moreland, Malavika Deodhar, M. Harler, Carrie Saulsbery, and Rebecca S. Kunder. 2024. “Cutting-edge approaches to B-cell depletion in autoimmune diseases.” Frontiers in Immunology 15: 1454747. https://doi.org/10.3389/fimmu.2024.1454747.
Harvard
Robinson, W. H. et al. (2024) ‘Cutting-edge approaches to B-cell depletion in autoimmune diseases’, Frontiers in Immunology, 15, p. 1454747. doi:10.3389/fimmu.2024.1454747.
IEEE
W. H. Robinson et al., “Cutting-edge approaches to B-cell depletion in autoimmune diseases,” Frontiers in Immunology, vol. 15, p. 1454747, 2024, doi: 10.3389/fimmu.2024.1454747.
BibTeX
@article{robinson2024cutting,
title = {{Cutting-edge approaches to B-cell depletion in autoimmune diseases}},
author = {Robinson, William H. and Fiorentino, David Franklin and Chung, Lorinda S and Moreland, Larry W. and Deodhar, Malavika and Harler, M. and Saulsbery, Carrie and Kunder, Rebecca S.},
journal = {Frontiers in Immunology},
year = {2024},
volume = {15},
pages = {1454747},
doi = {10.3389/fimmu.2024.1454747},
url = {https://doi.org/10.3389/fimmu.2024.1454747}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- B-cell depletion therapy
- autoimmune disease
- anti-CD20 monoclonal antibody
- antibody-dependent cellular cytotoxicity
- complement-dependent cytotoxicity
- antibody-dependent cellular phagocytosis
- bispecific T-cell engagers
- CAR T-cell therapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Robinson, W. H., Fiorentino, D. F., Chung, L. S., Moreland, L. W., Deodhar, M., Harler, M., Saulsbery, C., & Kunder, R. S. (2024). Cutting-edge approaches to B-cell depletion in autoimmune diseases. Frontiers in Immunology, 15, 1454747. https://doi.org/10.3389/fimmu.2024.1454747
How many times has this paper been cited?
53 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.
Who wrote this paper?
William H. Robinson, David Franklin Fiorentino, Lorinda S Chung, Larry W. Moreland, Malavika Deodhar, M. Harler, Carrie Saulsbery, Rebecca S. Kunder.
What is the DOI of this paper?
10.3389/fimmu.2024.1454747, permanently at https://doi.org/10.3389/fimmu.2024.1454747. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.